LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 6.06 | 84.90 | 829 | 365 | 2.2684 | 1.9509 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 6.06 | 84.90 | 672 | 365 | 1.8388 | 1.6708 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 6.06 | 84.90 | 2 | 365 | 0.0055 | -0.8313 | MN20160318_Q02 | K18 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.0033333 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | J09 |
| MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | J18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 6.06 | 84.90 | 2 | 365 | 0.0055 | -0.8313 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | C17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.06 | 84.90 | 768 | 365 | 2.1015 | 1.8457 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 6.06 | 84.90 | 899 | 365 | 2.4600 | 2.0667 | MN20160318_Q02 | I22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 6.06 | 84.90 | 769 | 365 | 2.1042 | 1.8474 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0033333 | 6.06 | 84.90 | 720 | 365 | 1.9702 | 1.7598 | MN20160318_Q02 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 6.06 | 84.90 | 3 | 365 | 0.0082 | -0.7955 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 6.06 | 84.90 | 747 | 365 | 2.0440 | 1.8085 | MN20160318_Q02 | L06 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.0033333 | 6.06 | 84.90 | 855 | 365 | 2.3396 | 1.9944 | MN20160318_Q02 | M22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 6.06 | 84.90 | 2 | 365 | 0.0055 | -0.8313 | MN20160318_Q02 | I22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.06 | 84.90 | 729 | 365 | 1.9948 | 1.7761 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 6.06 | 84.90 | 740 | 365 | 2.0249 | 1.7959 | MN20160318_Q02 | F11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 6.06 | 84.90 | 769 | 365 | 2.1042 | 1.8474 | MN20160318_Q02 | D21 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 6.06 | 84.90 | 796 | 365 | 2.1781 | 1.8945 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | L20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 6.06 | 84.90 | 720 | 365 | 1.9702 | 1.7598 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 6.06 | 84.90 | 794 | 365 | 2.1726 | 1.8910 | MN20160318_Q02 | L20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 6.06 | 84.90 | 3 | 365 | 0.0082 | -0.7955 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | D21 |